Clinical Trial Update: Study on the Safety and Tolerability of Postoperative Radiotherapy Concurrent With CDK4/6 Inhibitors in HR+/HER2- High-Risk Breast Cancer [EARLY_Phase 1]

View source ↗

Summary

This is an early-phase clinical trial evaluating the safety and tolerability of postoperative radiotherapy given concurrently with CDK4/6 inhibitors in hormone …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abemaciclib (abemaciclib)
• Palbociclib (palbociclib)
• Ribociclib (ribociclib)

Snippet

Sponsor: Guizhou Provincial People's Hospital | Conditions: Breast Cancer | EARLY_Phase 1 | Status: NOT_YET_RECRUITING